Hutchens Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Hutchens Investment Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,185	Closed	-$1.11M	–	67
2016 Q2	$1.11M	Buy	3,185 +2,300	+260%	+$886K	1.07%	44
2016 Q1	$318K	Buy	+885	New	+$365K	0.32%	57
2015 Q4	–	Sell	-2,925	Closed	-$1.36M	–	71
2015 Q3	$1.36M	Buy	2,925 +395	+16%	+$212K	1.43%	37
2015 Q2	$1.29M	Sell	2,530 -1,920	-43%	-$937K	1.22%	42
2015 Q1	$2.01M	Sell	4,450 -2,500	-36%	-$1.06M	1.85%	30
2014 Q4	$2.85M	Buy	+6,950	New	+$2.73M	2.6%	2

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Hutchens Investment Management's REGN Position: Q3 2016 in Review

Hutchens Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2016, closing a stake of 3,185 shares — an estimated $1.11M sold.

Hutchens Investment Management first reported a position in REGN in Q4 2014 and held it in 6 quarters. The position peaked at $2.85M in Q4 2014. 554 funds tracked by Wall St. Rank hold REGN as of Q3 2016.

Hutchens Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Hutchens Investment Management sold 3,185 Regeneron Pharmaceuticals shares in Q3 2016, an estimated $1.11M.
Hutchens Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 6 quarters.
Hutchens Investment Management's Regeneron Pharmaceuticals position peaked at $2.85M in Q4 2014.
554 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2016.

Based on Hutchens Investment Management's 13F filing for Q3 2016, filed 21 Oct 2016.